Yamamoto, Kei <br/><br/>
Tumor-infiltrating M2 macrophage in pretreatment biopsy sample predicts response to chemotherapy and survival in esophageal cancer.  [electronic resource] 

 -  Cancer science  Apr 2020 
 - 1103-1112 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1349-7006 
<br/><br/><label>Standard No.: </label>10.1111/cas.14328  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antigens, CD--blood<br/>Antigens, Differentiation, Myelomonocytic--blood<br/>Biomarkers, Tumor--blood<br/>Biopsy<br/>Cell Lineage--drug effects<br/>Cisplatin--administration & dosage<br/>Disease-Free Survival<br/>Docetaxel--administration & dosage<br/>Esophageal Neoplasms--blood<br/>Female<br/>Fluorouracil--administration & dosage<br/>Forkhead Transcription Factors--blood<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Kaplan-Meier Estimate<br/>Leukocyte Count<br/>Lymphocytes, Tumor-Infiltrating--drug effects<br/>Macrophages--drug effects<br/>Male<br/>Middle Aged<br/>Neoadjuvant Therapy<br/>Prognosis<br/>Programmed Cell Death 1 Receptor--blood<br/>Receptors, Cell Surface--blood<br/>Tumor Microenvironment--drug effects<br/>CD163 Antigen